GlassScriptPhysician profile
Oscar A Lopez
NPI 1205034733
$2,093.70
in general payments reported to CMS, 2019-2025
15 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $649 · 2021: $455 · 2022: $203 · 2023: $93.23 · 2024: $160 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.15 | 2019-2023 | |
| Phathom Pharmaceuticals, INC. | $259.43 | 2024-2025 | Voquezna |
| Daiichi Sankyo INC. | $208.28 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $171.90 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.15 | 2020-2022 | |
| Genzyme Corporation | $125.75 | 2025 | |
| Intercept Pharmaceuticals, INC. | $113.45 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.76 | 2020-2021 | |
| Pentax of America, INC. | $62.38 | 2023 | |
| Intuitive Surgical, INC. | $58.07 | 2019 | |
| Shionogi INC | $40.78 | 2019 | |
| Redhill Biopharma INC. | $29.97 | 2020 | |
| Boston Scientific Corporation | $28.27 | 2020 | |
| Fujifilm Healthcare Americas Corporation | $25.60 | 2024 | Fujifilm |
| Conmed Corporation | $14.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.